NASA, NSBRI Select 17 Proposals in Space Radiatio...(out NSBRI visit: ...),Health
Navigation Links
NASA, NSBRI Select 17 Proposals in Space Radiation Research
Date:9/24/2007
out NSBRI, visit:
'/>"/>
| SOURCE NASA Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Selective eating just an evolutionary trait?
2. New Study Questions Cannibalism As A Worldwide Selective Force
3. Govt to Pass Amendment to Curb Sex Selective Abortions: Ramadoss
4. Malaysia Likely To Outlaw Gender Selection Test
5. UK Government to Outlaw Sex Selection of Babies
6. Parental Role In Embryo-Selection Urged
7. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
8. Fertility Clinics Allowing Parents To Select Gender
9. DNA- A Dependable Determinant to Select Treatment Plan for Alcoholics
10. Embryonic Selection of Sex can Avoid Conceiving Blind Children
11. Selective Marker Found to Indicate Aggressive Form of Breast Cancer
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Procter & Gamble Announces Appointment of Director 2Health News:Possible ovarian cancer treatment target identified 2Health News:Testosterone Gets Bad Rap: Study 2Health News:Testosterone Gets Bad Rap: Study 3
[1] Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays[0] Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009[0] Procter & Gamble Announces Appointment of Director[0] Possible ovarian cancer treatment target identified[0] Testosterone Gets Bad Rap: Study
Other Medicine News:Health News:Glaucoma Awareness Not Just for Humans 2Health News:Glaucoma Awareness Not Just for Humans 3Health News:Pennsylvania Patient Safety Authority Launches New Website and Design With New Tagline 'Analyzing, Educating and Collaborating for Patient Safety' 2Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:Scientists call up stem cell troops to repair the body using new drug combinations 2Health News:Scientists call up stem cell troops to repair the body using new drug combinations 3Health News:Each State to Receive Report Card Grading Their Progress in Passing Model Traffic Safety Laws 2
Photos: Ifrenel s.a. Acne Skin Therapy Offers a Revolutionary New Solution For Fighting Problem SkinGlaucoma Awareness Not Just for HumansPennsylvania Patient Safety Authority Launches New Website and Design With New Tagline 'Analyzing, Educating and Collaborating for Patient Safety'Special Olympics Minnesota Launches Project UNIFY to Energize YouthScientists call up stem cell troops to repair the body using new drug combinationsEach State to Receive Report Card Grading Their Progress in Passing Model Traffic Safety Laws
Breaking Medicine Technology:Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Healthcare Reform Could Raise Premiums for Young Adults 56129 1Healthcare Reform Could Raise Premiums for Young Adults 56129 2Healthcare Reform Could Raise Premiums for Young Adults 56129 3Excuse Me Your Life Is Waiting 21 3A A Bridge from Addiction to Early Recovery 56125 1Excuse Me Your Life Is Waiting 21 3A A Bridge from Addiction to Early Recovery 56125 2Cantel Medical Corp To Present at the CL King 7th Annual Best Ideas Conference 56121 1
[0] Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System[0] AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa[0] Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation
Other Medicine Technology:Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients 2Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 2Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 3Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 4Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 5Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate 6
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |